We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
Cap. Flow
-$2.77B
Cap. Flow %
-10.63%
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$366M
2
MSFT icon
Microsoft
MSFT
+$279M
3
AMZN icon
Amazon
AMZN
+$213M
4
TSLA icon
Tesla
TSLA
+$109M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Consumer Staples 11.79%
3 Consumer Discretionary 11.57%
4 Industrials 10.74%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMRT icon
1701
SmartRent
SMRT
$183M
$30K ﹤0.01%
13,367
-2
-0% -$8
VXRT
1702
DELISTED
Vaxart
VXRT
$30K ﹤0.01%
13,652
-260
-2% -$897
OMIC
1703
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$30K ﹤0.01%
404
+12
+3% +$1.25K
GOEV
1704
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$30K ﹤0.01%
34
+6
+21% +$8.75K
URG
1705
Ur-Energy
URG
$485M
$26K ﹤0.01%
23,085
-442
-2% -$525
CRGE
1706
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$26K ﹤0.01%
14,341
+2,193
+18% +$6.25K
MKFG
1707
DELISTED
Markforged Holding Corporation
MKFG
$25K ﹤0.01%
1,214
-23
-2% -$532
DBD
1708
DELISTED
Diebold Nixdorf Incorporated
DBD
$25K ﹤0.01%
10,079
-237
-2% -$791
BARK icon
1709
BARK
BARK
$74.8M
$24K ﹤0.01%
658
-129,074
-99% -$4.77M
BBIG
1710
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$24K ﹤0.01%
1,254
+223
+22% +$4.44K
AMRX icon
1711
Amneal Pharmaceuticals
AMRX
$5.72B
$23K ﹤0.01%
11,353
-216
-2% -$605
NEUE
1712
DELISTED
NeueHealth
NEUE
$23K ﹤0.01%
266
-5
-2% -$664
RNAC icon
1713
Cartesian Therapeutics
RNAC
$232M
$21K ﹤0.01%
428
+34
+9% +$1.87K
AEVA
1714
Aeva Technologies
AEVA
$1.02B
$20K ﹤0.01%
2,136
-41
-2% -$648
CENN icon
1715
Cenntro
CENN
$8.23M
$20K ﹤0.01%
34
SMMT icon
1716
Summit Therapeutics
SMMT
$10.9B
$20K ﹤0.01%
+16,925
New +$19.1K
UP icon
1717
Wheels Up
UP
$220M
$20K ﹤0.01%
88
-1
-1% -$401
VLDR
1718
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$20K ﹤0.01%
21,286
-406
-2% -$474
HLGN
1719
DELISTED
Heliogen, Inc.
HLGN
$18K ﹤0.01%
+286
New +$22.3K
PRTY
1720
DELISTED
Party City Holdco Inc.
PRTY
$18K ﹤0.01%
12,020
-231
-2% -$388
OTLK icon
1721
Outlook Therapeutics
OTLK
$264M
$16K ﹤0.01%
653
-12
-2% -$279
XXII
1722
22nd Century Group
XXII
$1.47M
0
VIEW
1723
DELISTED
View, Inc. Class A Common Stock
VIEW
$16K ﹤0.01%
205
-4
-2% -$455
VLTA
1724
DELISTED
Volta Inc.
VLTA
$16K ﹤0.01%
13,470
-259
-2% -$525
OUST icon
1725
Ouster
OUST
$2.29B
$15K ﹤0.01%
1,575
+41
+3% +$631

Similar funds

ProShare Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.

  • ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
  • ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
  • ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
  • ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
  • ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
  • ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
  • ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.

Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.